The Supreme Court has delayed making a decision on whether to restrict access to mifepristone, a widely used abortion pill, until at least Friday, April 21, 2023, reports AP.
Pro-life advocates are seeking to limit the use of the drug, which is used in the most common method of abortion in the US. The justices may allow restrictions on mifepristone ordered by a lower court to take effect while a legal challenge to the medication's Food and Drug Administration approval continues.
The Biden administration and New York-based Danco Laboratories, the maker of the drug, want the Supreme Court to reject limits on mifepristone’s use imposed by lower courts, at least as long as the legal case makes its way through the courts. Alliance Defending Freedom, representing pro-life doctors and medical groups, is calling on the Supreme Court to restrict access to the drug now.
The court is scheduled to meet privately on Friday to discuss the issue.
The complete AP report can be read here: https://apnews.com/article/supreme-court-mifepristone-abortion-drug-8457b38f7a4799778e894da1858c8aa2